Clinical Trial Update: (-)-Epicatechin and Pulmonary Arterial Hypertension [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating (-)-Epicatechin for pulmonary arterial hypertension has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Epicatechin ((-)-Epicatechin)

Snippet

Sponsor: University of California, San Francisco | Conditions: Pulmonary Arterial Hypertension | Phase 1 | Status: WITHDRAWN